Recent Advances in Gastro-Retentive Drug Delivery Systems
DOI:
https://doi.org/10.37285/ijpsn.2016.9.3.1Abstract
Controlled gastric retention of solid dosage form may be achieved by the mechanisms of floatation, muco-adhesion, sedimentation, expansion or by a modified shaped system. The purpose of this paper is to review the recent literature and current technology used in the development of gastroretentive drug delivery systems. Oral sustained release gastroretentive dosage forms offer many advantages for drugs having absorption from upper gastrointestinal tract and improve the bioavailability of medications that are characterized by a narrow absorption window. Gastroretention would also facilitate local drug delivery to the stomach and proximal small intestine. So, gastroretention could help to provide greater availability of new products and consequently improved therapeutic activity and required benefits to patients. The purpose of writing the article was to compile the recent literature with special focus on various gastroretentive approaches that have recently become leading methodologies in the field of site-specific orally administered controlled release drug delivery. In particular, bioadhesive, size-increasing and floating drug delivery systems are presented and their major advantages and shortcomings are critically discussed in this review. Thus, gastroretention could help to provide greater availability of new products and consequently improved therapeutic activity and substantial benefits to patients
Downloads
Metrics
Keywords:
Non-effervescent systems, floating microspheres, size-increasing drug delivery systems, superporous hydrogel, magnetic marker monitoring
Downloads
Published
How to Cite
Issue
Section
References
Abdel-Rahman AA, Aboutaleb AE, Stamm A, Abdel-Rahman SI and Samy EM. (1992). Optimization of Eudragit or cellulosic polymers ibuprofen sustained release systems using principal component analysis. Bull Pharm Sci 15: 63-82.
Achanta AS, Kowalski JG and Rhodes CT. (1995). Artificial neural networks: Implications for pharmaceutical sciences. Drug Dev Ind Pharm 21: 119-155.
Agarwal V and Mishra B. (1999). Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Dev Ind Pharm 25: 701-709.
Ahn JS, Choi HK, Chun MK, Ryu JM, Jung JH, Kim YU and Cho CS. (2002). Release of triamcinolone acetonide from mucoadhesive polymer composed of chitosan and poly (acrylic acid) in vitro. Biomaterials 23: 1411-1416.
Ahrabi SF, Madsen G, Dyrstad K, Sande SA and Graffner C. (2000). Development of pectin matrix tablets for colonic delivery of model drug ropivacaine. Eur J Pharm Sci 10: 43-52.
Ahuja A, Khar RK and Ali J (1997). Mucoadhesive drug delivery systems. Drug Dev Ind Pharm 23: 489-492.
Akiyama A, Nagahara N, Nara E, Kitano M, Iwasa S, Yamamoto I, Azuma J and Ogawa Y. (1997). Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites. J Pharm Pharmacol 50: 159-166.
Ali J, Arora S, Ahuja A, Babbar AK, Sharma RK, Khar RK and Baboota S. (1997). Formulation and development of hydrodynamically balanced system for metformin: In vitro and in vivo evaluation. Eur J Pharm Biopharm 28: 1727
Asghar LF and Chandran S. (1997). Multiparticulate formulation approach to colon specific drug delivery: Current Perspectives. J Pharm Sci 9: 327-338.
Ashley JJ and Levy G. (1997). Effect of vehicle viscosity and an anticholinergic agent on bioavailability of a poorly absorbed drug (phenolsulfonphthalein) in man. J Pharm Sci 62: 688-690.
Aspden TJ, Mason JDT, Jones, NS, Lowe J, Skaugrud O and Illum L. (1997). Chitosan as a nasal delivery system: The effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J Pharm Sci 86: 509-513.
Asrani K. (1994). Evaluation of bioadhesive properties of poly-(acrylic acid) polymers and design of a novel floating bioadhesive drug delivery system. Doctoral thesis. St John's University, Jamaica, New York pp. 353-356.
Atyabi F, Sharma HL, Mohammad HAH and Fell JT. (1996). Controlled drug release from coated floating ion exchange resin beads. J Control Release 42: 25-28.
Babu VB and Khar RK. (1990). In vitro and in vivo studies of sustained-release floating dosage forms containing salbutamol sulfate. Pharmazie 45: 268-270.
Bain DF, Cox JE, Ambruso YD and Shakoor O. (2002). Simplex lattice design for optimization of a buccoadhesive tablet for sustained release of hydrophobic drugs. In: Proceedings of 29th Annual Meeting of Controlled Release Society; Seoul, Korea, Abstract 258.
Bamba M, Puisieux F, Marty JP and Carstensen JT. (1979). Release mechanisms in gel forming sustained release preparations. Int J Pharm 2: 307-315.
Bansal AK. (2003). Peroral controlled drug delivery systems: Future trends. Pharma Technology 39-41.
Baumgartner S, Kristl J, Vrecer F, Vodopivec P and Zorko B. (2000). Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int J Pharm 195: 125-135.
Baumgartner S, Tivador A, Vrecer F and Kristl JO. (2001). Development of floating tablets as a new approach to the treatment of Helicobector Pylori infections. Acta Pharm 51: 21-33.
Baveja SK, Rao KVR and Devi KP. (1985). Sustained release tablet formulation of diethylcarbamazine. Part III. Int J Pharm 27: 157-162.
Baveja SK and Rao KVR. (1986). Sustained release tablet formulation of centperazine. Int J Pharm 31: 169-174.
Bechgaard H and Baggeson S. (1980). Propoxyphene and nor propoxyphene: Influence of type of controlled release formulation on intra- and inter-subject variations. J Pharm Sci 69: 1327-1330.
Bechgaard H and Ladefoged K. (1978). Distribution of pellets in the gastrointestinal tract: The influence of transit time exerted by the density or diameter of pellets. J Phram Pharmacol 30: 690-692.
Bernkop-Schnurch A and Walker G. (2001). Multifunctional matrices for oral peptide delivery. Crit Rev Ther Drug Carrier Syst 18: 459-501.
Bodea A and Leucuta SE. (1997). Optimization of hydrophilic matrix tablets using a d-optimal design. Int J Pharm 153: 247-255.
Bodwan AA, Abumalooh A, Krogel, Sallam E, Abukalaf A and Jawan O. (1995). A sustained release drug delivery system using calcium alginate beads. Drug Dev Ind Pharm 11: 239-256.
Bonferoni MC, Rossi S, Ferrari F, Bertoni M and Caramella C. (1998). On the employment of carrageenan in a matrix system. Part 3. Optimization of a carrageenan-HPMC hydrophilic matrix. J Control Release 51: 231-239.
Borgquist P, Nevsten P, Nilsson B, Wallenberg LR and Axelsson A. (2004). Simulation of the release from a multiparticulate system validated by single pellet and dose release experiments. J Control Release 97: 453–465.
Bottenberg P, Cleymaet R, de Muynck C, Remon JP, Coomans D, Michotte Y and Slop D. (1991). Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use. J Pharm Pharmacol 43: 457-464.
Bouckaert S and Remon JP. (1993b). In vitro bioadhesion of a buccal, miconazole slow-release tablet. J Pharm Pharmacol 45: 504-509.
Bouckaert SL, Lefebvre RA, Colardyn F and Remon JP. (1993a). Influence of the application site on bioadhesion and slow release characteristics of a bioadhesive buccal slow-release tablet of miconazole. Eur J Clin Pharmacol 44: 331-335.
Boza A, De la Cruz Y, Jordan G, Jauregui-Haza U, Aleman A and Caraballo I. (2000). Statistical optimization of a sustained-release matrix tablet of lobenzarit disodium. Drug Dev Ind Pharm 26: 1303-07.
Brabander CD, Vervact C, Gortz JP, Remon JP and Berlo JX. (2000). Bioavailability of Ibuprofen from Matrix Mini-tablets based on a mixture of starch and microcrystalline wax. Int J Pharm 208: 81-86.
Bulgarelli E, Forni F and Bernabei MT. (2000). Effect of matrix composition and process conditions on casein-gelatin beads floating properties. Int J Pharm 198: 157-165.
Burns SJ, Attwood D and Barnwell SG. (1998). Assessment of the dissolution vessel designed for use with floating and erodible dosage form. Int J Pharm 160: 213-18.
Cargill R, Cadwell LJ, Engle K, Fix JA, Porter PA and Gardner CR. (1988). Controlled gastric emptying: I. Effects of physical properties on gastric residence times of nondisintegrating geometric shapes in beagle dogs. Pharm Res 5: 533-536.
Carla Lopes M, Jose Sousa Lobo M, Joao Pinto F and Paulo Costa C. (2007). Compressed Matrix Core Tablet as a Quick/Slow Dual-Component Delivery System Containing Ibuprofen. AAPS Pharm Sci Tech 8: E195–E202.
Carla Lopes M, Jose Souza lobo M, Jaao Pinto F and Paulo Costa C. (2006). Compressed Mini-tablets as a biphasic delivery system. Int J Pharma 323: 93-100.
Chauhan B, Shimpi S, Mahadik KR and Paradkar A. (2004). Preparation and evaluation of floating risedronate sodium Gelucire 39/01 matrices. Acta Pharm 54: 205-214.
Chavanpatil M, Jain P, Chaudhari S, Shear R and Vavia P. (2005). Development of sustained release gastroretentive drug delivery system for ofloxacin: In vitro and in vivo evaluation. Int J Pharm 304: 178-184.
Chavanpatil MD, Jain P, Chaudhari S, Shear R and Vavia PR. (2006). Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int J Pharm 316: 86-92.
Chawla G, Gupta P, Koradia V and Bansal AK. (2003). Gastroretention: A means to address regional variability in intestinal drug absorption. Pharm Tech 27: 50-68.
Chen GL and Hao WH. (1998). In vitro performance of floating sustained release capsule of verapamil. Drug Dev Ind Pharm 24: 1067-1072.
Chien YW. (1992). Oral drug delivery and delivery systems. In: Novel Drug Delivery Systems. Marcel Dekker, New York. pp. 139-96.
Chitnis VS, Malshe VS and Lalla JK. (1991). Bioadhesive polymers-synthesis, evaluation and application in controlled release tablets. Drug Dev Ind Pharm 17: 879-892.
Ch'ng HS, Park H, Kelly P and Robinson JR. (1985). Bioadhesive polymers as platforms for oral controlled drug delivery. Part 2. Synthesis and evaluation of some swelling, water insoluble bioadhesive polymers. J Pharm Sci 74: 399-405.
Choi BY, Park HJ, Hwang SJ and Park JB. (2002). Preparation of alginate beads for floating drug delivery system: Effects of CO2 gas-forming agents. Int J Pharm 239: 81-91.
Chowdary KPR and Srinivas L. (2000). Mucoadhesive drug delivery systems: A review of current status. Ind Drugs 37: 400-03.
Chowdary KPR, Suresh B, Sangeeta B and Reddy GK. (2003). Design and evaluation of diltiazem mucoadhesive tablets for oral controlled Release Saudi. Pharm J 11: 201-205.
Chu JS, Amidon GL, Weiner ND and Goldberg AH. (1991b). Mixture experimental design in the development of a mucoadhesive gel formulation. Pharm Res 8: 1401-1407.
Chu JS, Chandrasekharan R, Amidon GL, Weiner ND and Goldberg AH. (1991a). Viscometric study of polyacrylic acid systems as mucoadhesive sustained-release gels. Pharm Res 8: 1408-12.
Chueh, HR, Zia H and Rhodes CT. (1995). Optimization of sotalol floating and bioadhesive extended release tablet formulations. Drug Dev Ind Pharm 21: 1725-47.
Collins PW, Trement SJ, Perkins WE, Fenton RL, McGroth MP, Wagner GM, Gasiecki AF, Bianchi RG, Caslea JJ, Pante CM, Stozenbach JC, Jones PH and Forster D. (1994). Polymeric site directed delivery of misoprostol to the stomach. American Chemical Society, Washington, DC.
Colombo P, Provasi D, Borazzo MG, Maggi L and Catellani PL. (1989). The role of compression force in floating tablet formula optimization. Acta Pharm Technol 35: 168-70.
Cremer K. (1997). Drug delivery: Gastro-remaining dosage forms. Pharm J pp. 259.
Critchley HD, SS, Farrag NF and Illum L. (1994). Nasal absorption of desmopressin in rats and sheep. Effect of a bioadhesive microsphere delivery system. J Pharm Pharmacol 46: 651-56.
Cromer AH. (1981). Physics for the life sciences. McGraw-Hill Intern. Book Co., Tokyo, pp. 134-53.
Danckwerts MP, Van der Watt, JG and Moodley I. (1996). The effect of processing variables on the release of ibuprofen and caffeine from controlled-release nonswellable core-in-cup compressed tablets. Drug Dev Ind Pharm 22: 681-687.
Dangprasirt P and Ritthidej GC. (1997). Development of diclofenac sodium controlled release solid dispersion tablet using optimization strategy. Drug Dev Ind Pharm 23: 843-848.
Dave BS, Amin AF and Patel MM. (2004). Gastroretentive drug delivery system of ranitidine hydrochloride: Formulation and in vitro evaluation. AAPS Pharm Sci Tech 5: Article 34.
Davis DW (1968). Methods of swallowing a pill. US Patent, 3418999.
Davis SS. (1986). Evaluation of the gastrointestinal transit of pharmaceutical dosage forms using the technique of gamma scintigraphy. STP Pharm Sci 2: 1015-1022.
Davis SS. (2005). Formulation strategies for absorption windows. Drug Deliv Tech pp. 10.
Dennis A, Timmins P and Lee K (1992). Buoyant controlled release powder formulation. US Patent, 5169638.
Desai S and Bolton S. (1993). A floating controlled-release drug delivery systems: In vitro-in vivo evaluation. Pharm Res 10: 1321-1325.
Deshpande AA, Rhodes CT, Shah NH, Malick AW. (1996). Controlled-release drug delivery systems for prolonged gastric residence: An overview. Drug Dev Ind Pharm 22: 531-539.
Deshpande AA, Shah NH, Rhodes CT and Malick W. (1997). Development of a novel controlled-release system for gastric retention. Pharm Res 14: 815-819.
Devarajan PV and Adani MH (1997). Oral transmucosal drug delivery. In: Jain NK. (ed.) Controlled and Novel Drug Delivery. Ist edn. CBS Publishers, New Delhi, pp. 52-81.
Dew HJ, Ryder RE, Evans N and Rhodes J. (1983). Colonic release of 5-ASA from an oral prepration in active ulceration colitis. Braz J Clin Pharmacol 165: 185-188.
Dey NS, Majumdar S and Rao MEB. (2008). Multiparticulate drug delivery systems for controlled release. Tro J Pharm Res 7: 1067-1075.
Dincer S and Ozdurmus S. (1977). Mathematical model for enteric film coating of tablets. J Pharm Sci 66: 1070-1073.
Dittgen M, Oestereich S and Eckhardt D. (1991). The effect of bioadhesiveness of viscous solutions with naphazoline hydrochloride on the elimination of the drug from the eye of swine. Pharmazie 46: 716-718.
Dodou D, Breedveld P and Wieringa PA. (2005). Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications. Eur J Pharm BioPharm 60: 1-16.
Dorozynski P, Jachowicz R, Kulinowski P, Kwiecinski S, Szybinski K, Skorka T and Jasinski A. (2004). The macromolecular polymers for the preparation of hydrodynamically balanced systems-methods of evaluation. Drug Dev Ind Pharm 30: 947-957.
Duchene D, Touchard F and Peppas NA. (1988). Pharmaceutical and medical aspects of bioadhesive systems for drug administration. Drug Dev Ind Pharm 14: 283-318.
El-Gibaly I, Meki AMA and Abdel-Ghaffar SK. (2003). Novel B melatonin-loaded chitosan microcapsules: In vitro characterization and antiapoptosis efficacy for aflatoxin B1-induced apoptosis in rat liver. Int J Pharm 260: 5-22.
El-Kamel AH, Sokar MS, Al Gamal SS and Naggar VF. (2001). Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharm 220: 13-21.
Elkheshen SA and Hosny EA. (1999). Bioadhesive matrix as a controlled-release dosage form for verapamil hydrochloride: Effect of mixing polymers on water uptake of the matrix and the drug release rate using a simplex lattice design. Pharm Ind 61: 666-670.
Erni W and Held K. (1987). The hydrodynamically balanced system: A novel principle of controlled drug Release. Eur Neurol 27: 21S.
Eroglu M, Irmak S, Acar A and Denkbas EB. (2002). Design and evaluation of a mucoadhesive therapeutic agent delivery system for postoperative chemotherapy in superficial bladder cancer. Int J Pharm 235: 51-59.
Fabregas JL. (1994). In vitro testing of an antacid formulation with a prolonged gastric residence time. Drug Dev Ind Pharm 20: 1199-1212.
Farid RM (2012). Drug dosage forms 11 (PHR 312), Lecture 5, Tablet coating and types of tablets, Pharos university in Alexandria (PUA) www.pua.edu.eg/.
Fassihi R, Fabian J and Sakr AM. (1996). Application of response surface methodology to design optimization in formulation of a typical controlled release system. Drugs Made in Germany 39: 122-126.
Fell JT, Whitehead L and Colletts JH. (2000). Prolonged gastric retention using floating dosage forms. Pharm Tecnol pp. 82-90.
Ferrari F, Bertoni M, Bonferoni CM, Rossi S and Caramella C. (1996). Dissolution enhancement of an insoluble drug by physical mixture with a superdisintegrant: Optimization with a simplex lattice design. Pharm Dev Tech 1: 159-164.
Fix JA, Cargill R and Engle K. (1993). Controlled gastric emptying III. Gastric residence time of a nondisintegrating geometric shape on human volunteers. Pharm Res 10: 1087-89.
Fontana G, Licciardi M, Mansueto S, Schillaci D and Giammona G. (2001). Amoxicillin-loaded polyethylcyanoacrylate nanoparticles: Influence of PEG coating on the particle size, drug release rate and phagocytic uptake. Biomaterials 22: 2857-2865.
Ford JL, Rubinsteina MH and Hoganb JE. (1985). Formulation of sustained release promethazine hydrochloride tablets using hydroxypropyl-methylcellulose matrices. Int J Pharm 24: 327-338.
Franz MR and Oth MP (1993). Sustained-release, bilayer buoyant dosage form. US Patent, 5232704.
Franz RM, Sytsma JA, Smith BP and Lucisano LJ. (1987). In vitro evaluation of a mixed polymeric sustained release matrix using reponse surface methodology. J Control Release 5: 159-172.
Friedman, M. and Kirmayer, D. (2011). Novel gastroretentive delivery system, US20110268666
Galovic R, Barisic K, Pavelic Z, Zanic Grubisic T, Cepelak I and Filipovic-Grcic J. (2002). High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes. Eur J Pharm Sci 15: 441-448.
Gander B, Gurny R and Doelker E. (1986). Matrices for controlled liberation of drugs from polymers. I. Mechanisms of the penetration of solvents into polymers. Pharm Acta Helv 61: 130-134.
Gandhi RB and Robinson JR. (1988). Bioadhesion in drug delivery. Ind J Pharm Sci 50: 145-152.
Gansbeke BV, Timmermans J, Schoutens A and Mojes AJ. (1991). Intragastric positioning of two concurrently ingested pharmaceutical matrix dosage forms. Nucl Med Biol 18: 711-718.
Gardner CR (1985). Gastrointestinal Barrier to Oral Drug Delivery. Human press, New Jersey.
Garg S and Sharma S. (2003). Gastro retentive Drug Delivery Systems. Business Briefing Pharm Tech pp. 160-166.
Gavini E, Rassu G, Sanna S, Cossu M and Giunchedi P. (2005). Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro/ex-vivo studies. J Pharm Pharmcol 57: 287-94
Geoffroy JM, Fredrickson JK and Shelton JT. (1998). A mixture experiment approach for controlling the dissolution rate of sustained release tablet. Drug Dev Ind Pharm 24: 799-806.
Gergogiannis YS, Rekkas DM, Dallos PP and Chailis NH. (1993). Floating and swelling characteristics of various excipients used in controlled release technology. Drug Dev Ind Pharm 19: 1061-1081.
Gibaly IE. (2002). Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: Comparison with non-floating chitosan microsphe. Res Int J Pharm 249: 7-21.
Gibb DM and Goodall RL. (2003). Adherence to prescribed antiretroviral therapy in human immunodeficiency virus infected children in the PENTA 5 trail. Pediatric Inf Dis J 22: 56-62.
Gil EC, Colarte AI, Bataille B, Pedraz JL, Rodriguez F and Heinamaki J. (2006). Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride. Int J Pharm 317: 32-39.
Gohel MC, Amin AF, Chhabaria MT, Panchal MK and Lalwani AN. (2000). Modulation of drug release rate of diltiazem-HCl from hydrogel matrices of succinic acid-treated ispaghula husk. Pharm Dev Technol 5: 375-381.
Gohel MC, Jani GK, Patel NK and Gondaliya DP. (1998). Optimization of hydrophilic matrix tablet formulation of diclofenac sodium using a mixture design. Pharm Pharmacol Commun 4: 433-438.
Gohel MC and Panchal MK. (1999). Formulation optimization of diltiazem-HCl matrix tablets containing modified guar gum using a central composite design. Pharm Pharmacol Commun 5: 331-338.
Gohel MC, Patel KV, Panchal MK, Doctor BB and Shah PD. (1999). Application of simplex lattice design to the preparation of sustained-release diltiazem hydrochloride tablets using modified guar gum. Indian J Pharm Sci 61: 162-167.
Gohel MC and Patel KV. (1997). Formulation optimization of diltiazem hydrochloride matrix tablets containing modified ispaghula husk using factorial design. Drug Dev Ind Pharm 23: 1055-1061.
Gohel MC, Patel MM and Amin AF. (2003). Development of modified release diltiazem HCl tablets using composite index to identify optimal formulation. Drug Dev Ind Pharm 29: 565-574.
Grassi M, Vojnovich D, Franceschinis E and Perissutti B (2003). Controlled release from hydrophobic matrices obtained by melt extrusion. Proc. Control Rel. Soc., 30th Annual Meeting. Scottish Exhibition & Conference Centre, Glasgow, Scotland, U. K., pp. 433.
Groning R and Heun G. (1984). Dosage forms with controlled gastrointestinal transit. Drug Dev Ind Pharm 10: 527-539.
Gupta PK, Leung SS and Robinson JR (1990). Bioadhesives in drug delivery to the gastrointestinal tract. CRC Press, Boca Raton. pp. 65-92.
Gwen SS. (2002). Nocturnal asthma, mechanism and management. The Mount Sinai J Med 69: 140-147.
Haas J and Lehr CM. (2002). Developments in the area of bioadhesive drug delivery systems. Expert Opin Biol Ther 2: 287-298.
Hariharan M, Gupta V and Price JC. (1997). Optimization of sustained-release tablet formulations: A four component mixture experiment. Pharm Dev Technol 2: 365-371.
Harris D, Fell JT, Sharma HL and Taylor DC. (1990). Gastrointestinal transit of potential bioadhesive formulations in man: A scintigraphic study. J Control Release 12: 45-50.
Harris D, Fell JT, Taylor DC, Lynch J and Sharma HL. (1989). Oral availability of a poorly absorbed drug, hydrochlorothiazide, from a bioadhesive formulation in the rat. Int J Pharm 56: 97-102.
Harris MR, Schwartz JB and McGinity JW. (1985). Optimization of a slow release tablet formulation containing sodium sulphathiazole and a montmorrilonite clay. Drug Dev Ind Pharm 11: 1089-1110.
Hashim H and Liwan A. (1987). Improving the release characteristics of water-soluble drugs from hydrophilic sustained-release matrix by in situ gas generation. Int J Pharm 35: 201-209.
Hendee WR (1994). Textbook of diagnostic imaging II. In: Putman, C. E., Ravin, C. E. (eds.) Vol. 1, Sauners, W. B. Philadelphia. pp. 1-6.
Hewitt RR and Levy G. (1971). Effect of viscosity on thiamine and riboflavin absorption in man. J Pharm Sci 60: 784-786.
Hilton AK and Deasy PB. (1992). In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate. Int J Pharm 86: 79-88.
Hirata M, Takayama K and Nagai T. (1992). Formulation optimization of sustained release tablet of chlorpheniramine maleate by means of extreme vertices design and simultaneous optimization technique. Chem Pharm Bull 40: 741-746.
Horton RE, Ross FGM and Darling GH. (1965). Determination of the emptying-time of the stomach by use of enteric-coated barium granules. Br Med J pp. 1537-1539.
Hosny EA and Al-Meshal MA. (1994). In vivo evaluation of a bioadhesive containing indomethacin tablets. Drug Dev Ind Pharm 20: 2715-2720.
Hosny EA. (1996). Formulation and comparative evaluation of bioadhesive containing diclofenac sodium and commercial enteric coated tablets in-vitro and in dogs. Int J Pharm 133: 149-153.
Hou SYE, Cowles VE and Berner B. (2003). Gastric retention dosage form : A review. Crit Rev Ther Drug Carrier Syst 20: 461-497.
Huang JL and Lu JF. (2002). In vitro drug release profiles and mucoadhesive property of bioadhesive microspheres of metronidazole. Yao Xue Xue Bao 37: 226-228.
Huang Y, Khanvilkar KH, Moore AD and Hilliard-Lott M. (2003). Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose. Drug Dev Ind Pharm 29: 79-88.
Hue Vuong, Palmer D, Levina M, Ali Rajabi R and Siabhoomi (2008). Investigation of enteric coating of Mini-tablets using a perforated pan or a fluid Bed machine. Poster reprint Controlled Release Society Annual meeting.
Hue Vuong, Revina M, Rajab R and Siabhoomi (2008). Evaluation of the enteric performance of lansoprazole Mini-tablets coated in a perforated pan. Poster Reprint American Association of pharmaceutical Scientists (AAPS). Annual meeting.
Huglin MR. Hydrogels in medicine and pharmacy Edited by N. A. Peppas, CRC Press Inc., Boca Raton, Florida, 1986 (Vol. l), 1987 (Vols 2 and 3). Vol. 1 Fundamentals, pp. 180, Vol. 2 Polymers, pp. 171, Vol. 3 Properties and Applications, pp. 195.
Hui HW and Robinson JR. (1985). Ocular delivery of progesterone using a bioadhesive polymer. Int J Pharm 26: 203-208.
Hussain AS, Yu XQ and Johnson RD. (1991). Application of neural computing in pharmaceutical product development. Pharm Res 8: 1248-1252.
Iannuccelli V, Coppi G and Cameroin R. (1997). Intragastric behavior of a multiple-unit floating system. Int Symp Rel Bioact Mater 24: 403-404.
Iannuccelli V, Coppi G, Sansone R and Ferolla G. (1998). Air compartment multiple-unit system for prolonged gastric residence. Part II. In vivo evaluation. Int J Pharm 174: 55-62.
Ibric S, Jovanovic M, Djuric Z, Parojcic J, Petrovic S, Solomun L and Stupar B. (2003). Artificial neural networks in the modeling and optimization of aspirin extended release tablets with eudragit L100 as matrix substance. AAPS Pharm Sci Tech 4: 62-70.
Ibric S, Jovanovic M, Ðuric Z, Parojcic J and Solomun L. (2002). The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit(R) RS PO as matrix substance. J Control Release 82: 213-222.
Ichikawa M, Kato T, Kawahara M, Watanabe S and Kayano M. (1991a). A new multiple-unit oral floating dosage system. II. In vivo evaluation of floating and sustained-release characteristics with p-aminobenzoic acid and isosorbide dinitrate as model drugs. J Pharm Sci 80: 1153-56.
Ichikawa M, Watanabe S and Micyake Y. (1991b). A new multiple-unit oral floating dosage systems. I. Preparation and in vitro evaluation of floating and sustained-release characteristics. J Pharm Sci 80: 1062-1066.
Ingani HM, Timmersmans J and Moes AJ. (1997). Conception and in vivo investigation of peroral sustained-release floating dosage forms with enhanced gastrointestinal transit. Int J Pharm 35: 157-64.
Jain NK, Khar RK, Ahuja A and Ali J (1997). Controlled and Novel Drug Delivery. 1st edn. CBS Publishers, New Delhi. pp. 355-372.
Jain SK, Awasthi AM, Jain NK and Agrawal GP. (2005b). Calcium silicate based microspheres of repaglinide for gastroretentive floating drug delivery: Preparation and in vitro characterization. J Control Release 107: 300-309.
Jain SK, Jain NK and Agrawal GP. (2005a). Gastroretentive Floating Drug Delivery: An Overview. Drug Deliv. Technol. 5: 62-71.
Jauhari S, Dash and AKA. (2006). Mucoadhesive In Situ Gel Delivery System for Paclitaxel. AAPS Pharm Sci Tech 7: Article 53
Jayanthi G, Jayaswal SB and Srivastava AK. (1995). Formulation and evaluation of terfenadine microballons for oral controlled Release Pharmazie. 50: 769-770.
Jiang, Q., Zheng, J., Yang, W. and Liu, Q. (2011). Gastroretentive drug delivery system, preparation method and use thereof, US 20110171275.
Jimenez-Castellanos MR, Zia H and Rhodes CT. (1994). Design and testing in vitro of a bioadhesive and floating drug delivery system for oral application. Int J Pharm 105: 65-70.
Jimenez-Castellanos MR, Zia H and Rhodes CT. (1993). Mucoadhesive drug delivery systems. Drug Dev Ind Pharm 19: 143-194.
Johnson AD, Anderson VL, Peck GE (1990). Statistical approach for the development of an oral controlled-release matrix tablet. Pharm Res 7: 1092-1097.
Joly F and Brossard C (1987). Development of a hydrophilic matrix for theophylline. Part 1. Physical and mechanical properties of materials and optimization of formulation. STP Pharma Pratiques. 3: 556-568.
Jones DS and Pearce KJ. (1996). Contribution of process variables to the entrapment efficiency of propranolol hydrochloride within ethylcellulose microspheres prepared by the solvent evaporation method as evaluated using a factorial design. Int J Pharm 131: 25-31.
Joseph NJ, Lakshmi S and Jayakrishnan A. (2002). A floating type oral dosage form for piroxicam based on hollow polycarbonate microspheres: In vitro and in vivo evaluation in rabbits. J Control Release 79: 71-80.
Jug M and Becirevic-Lacan M. (2004). Influence of hydroxypropyl-[beta]-cyclodextrin complexation on piroxicam release from buccoadhesive tablets. Eur J Pharm Sci 21: 251-260.
Junginger HE, Thanou M and Verhoef JC (2002). Mucoadhesive hydrogels in drug delivery. In: Swarbrick, J. (ed.), Encyclopedia of Pharmaceutical Technology, Marcel Dekker, New York, pp. 1848-1863.
Kaelble DH. (1977). A surface energy analysis of bioadhesion. Polymer. 18: 475-482.
Kamath KR and Park K (1994). Mucosal adhesive preparation. In: Swarbrick J, Boylan JC, Encyclopedia of Pharmaceutical Technology. Marcel Dekker, New York. pp. 133-163.
Kannan V, Kandarapu R and Garg S. (2003). Optimization techniques for the design and development of novel drug delivery systems, part II. Pharm Tech.
Kawashima Y, Niwa T, Takeuchi H, Hino T and Ito Y. (1991). Prepration of multiple-unit hollow microspheres (microballoons) with acrylic resin containing traniplast and their drug release characteristics (in vitro) and floating behaviour (in vivo). J Control Release 16: 279-290.
Kawashima Y, Niwa T, Takeuchi H, Hino T and Ito Y. (1992). Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci 81: 135-140.
Khan MA, Dib J and Reddy IK. (1996). Statistical optimization of ketoprofen Eudragit S 100 coprecipitates to obtain controlled release tablets. Drug Dev Ind Pharm 22: 135-141.
Khan MA, Karnachi AA, Singh SK, Sastry SV and Bolton S. (1995). Controlled release coprecipitates: Formulation considerations. J Control Release 37: 131-141.
Khanna R, Agarwal SP and Ahuja A. (1997). Muco-adhesive buccal tablets of clotrimazole for oral candidiasis. Drug Dev Ind Pharm 23: 831-837.
Khanna R, Aggarwal SP and Ahuja A. (1998). Mucoadhesive buccal drug delivery: Potential alternative to conventional therapy. Indian J Pharm Sci 60: 1-11.
Khanvilkar KH, Huang Y and Moore AD. (2002). Influence of hydroxypropyl methylcellulose mixture, apparent viscosity and tablet hardness on drug release using a 23 full factorial design. Drug Dev Ind Pharm 28: 601-608.
Khattab IS, Abdel-rahman S, Khidr S and Abdel-Hakiem O. (2001). Development and optimization of sustained release captopril tablets and capsules. Egyptian J BioTech 10: 432-445.
Khattar D, Ahuja A and Khar RK. (1990). Hydrodynamically balanced systems as sustained release dosage forms for propranolol hydrochloride. Pharmazie. 45: 356-358.
Kim H and Fassihi R. (1997). A new ternary polymeric matrix system for controlled drug delivery of highly soluble drugs: I. Diltiazem hydrochloride. Pharm Res 14: 1415-1421.
Klausner EA, Lavy E, Stepensky D, Friedman M and Hoffman A. (2002). Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm Res 19: 1516-1523.
Kohri N. (1996). Improving the oral bioavialability of sulpiride by gastric-retained form in rabbits. J Pharm Pharmacol 48: 371-374.
Korsmeyer RW, Gurny R, Doelker E, Buri P and Peppas NA. (1983). Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: Effect of entrapped air. J Pharm Sci 72: 1189-1191.
Kristl A, Vojnovic D, Karba R, Mrhar A, Rubessa F and Zupani B. (1993). Mixture design of theophylline retard formulation. Int J Pharm 100: 33-40.
Krogel I, Bodmeier R. (1999a). Development of a multinational matrix drug delivery system surrounded by an impermeable cylinder. J Control Release 61: 43-50.
Krogel I and Bodmeier R. (1999b). Floating or pulsatile drug delivery systems based on coated effervescent cores Int J Pharm 187: 175-184.
Kumar MK, Shah MH, Ketkar A, Mahadik KR and Paradkar A. (2004). Effect of drug solubility and different excipients on floating behaviour and release from glyceryl monooleate matrices. Int J Pharm 272: 151-160.
Kumar S and Himmelstein KJ. (1995). Modification of in situ gelling behavior of carbopol solutions by hydroxypropyl methylcellulose. J Pharm Sci 84: 344-348.
Kurosaki Y, Takatori T, Kitayama M, Nakayama T and Kimura T. (1988). Application of propranolol to the keratinized oral mucosa: Avoidance of first-pass elimination and the use of 1-dodecylazacycloheptan-2-one (azone) as an absorption enhancer of bioadhesive film-dosage form. J Pharmacobiodyn. 11: 824-832.
Lapidus H and Lordi NG. (1966). Some factors affecting the release of a water-soluble drug from a compressed hydrophilic matrix. J Pharm Sci 55: 840-843.
Lavelle EC. (2001). Targeted delivery of drugs to the gastrointestinal tract. Crit Rev Ther Drug Carrier Syst. 18: 341-386.
Lee JH, Park JG and Choi HK. (2000). Effect of formulation and processing variables on the charcateristic of microspheres for water-soluble drugs prepared by w/o/w double emulsion-solvent diffusion method. Int J Pharm 196: 75-83.
Lee JH, Park TG and Choi HK. (1999). Development of oral drug delivery system using floating microspheres. J Micro-encapsulation 16: 715-729.
Lee JH, Park TG, Lee YB, Shin SC and Choi HK. (2001). Effect of adding non volatile oils as a core material for the floating microspheres prepared by emulsion solvent diffusion method. J Microencapsul. 18: 65-75.
Lee VHL and Robinson JR. (1979). Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits. J Pharm Sci 68: 673-684.
Lehr CM, Bouwastra JA, Kok W, De Boer AG, Tukker JJ, Verhoef JC, Breimer DD and Junginger HE. (1992b). Effects of the mucoadhesive polymer polycarbophil on the intestinal absorption of a peptide drug in the rat. J Pharm Pharmacol 44: 402-407.
Lehr CM, Bouwstra JA, De Boer AG, Verhoef JC, Breimer DD and Junginger HE (1992a). Intestinal bioadhesive drug delivery system. In: Junginger, H.E. (ed.) Drug Targeting and Delivery: Concepts in Dosage Form Design. Horwood, Great Britain.
Lehr CM, Poelma FGJ, Junginger HE and Tukker JJ. (1990). An estimate of turnover time of intestinal mucus gel layer in the rat in situ loop. Int J Pharm 70: 235-240.
Lejoyeux F, Ponchal G, Wouessidjewe D, Peppas NA and Duchene D. (1989). Bioadhesive tablets influence of the testing medium composition on bioadhesion. Drug Dev Ind Pharm 15: 2037-2048.
Leung SH and Robinson JR. (1990). Polymer structure features contributing to mucoadhesion. Part 2. J Control Release 12: 187-194.
Leung SH, Trans BK and Robinson JR. (1993). Polyanionic hydrogel as a gastric retention system. J Biomat Sci Polym 4: 483-492.
Leuβen HL, Lehr CM, Rentel CO, Noach ABJ, De Boer AG, Verhoef JC and Junginger HE. (1994). Bioadhesive polymers for the peroral delivery of peptide drugs. J Control Release 29: 329-338.
Levine DS, Raisis JR and Ainardi V. (1987). Coating of oral beclomethasone dipropionate capsules with cellulose aceto-phthalate enhances delivery of topically active anti-inflammatory drug to the terminal colon. Gastroenterol 92: 1137-1142.
Lewis GA, Mathieu D and Phan-Tan-Luu R (1999). Pharmaceutical experimental design. Drugs and Pharmaceutical Sciences, 1st Edn., Vol. 92 Marcel Dekker, New York.
Li J, Dong E, Li H and Pan W. (2003a). Studies on the factors influencing metformin hydrochloride release from matrix tablets and the optimization of formulation. Shenyang Yaoke Daxue Xuebao 20: 88-92.
Li LC and Peck GE. (1991). Water based silicone elastomer controlled release tablet film coating. Part 5. Statistical approach. Drug Dev Ind Pharm 17: 27-37.
Li LC and Tu YH. (1991). In vitro drug release from matrix tablets containing a silicone elastomer latex. Drug Dev Ind Pharm 17: 2197-2214.
Li S, Lin S, Chien YW, Daggy BP and Mirchandani HL. (2001). Statistical optimization of gastric floating system for oral controlled delivery of calcium. AAPS Pharm Sci Tech 2: 1-12.
Li S, Lin S, Daggy BP, Mirchandani HL and Chien YW. (2002). Effect of formulation variables on the floating properties of gastric floating drug delivery system. Drug Dev Ind Pharm 28: 783-793.
Li S, Lin S, Daggy BP, Mirchandani HL and Chien YW. (2003b). Effect of HPMC and Carbopol on the release and floating properties of gastric floating drug delivery system using factorial design. Int J Pharm 253: 13-22.
Longer MA, Ching, HS and Robinson JR. (1985). Bioadhesive polymers as platform for oral control drug delivery. III. Oral delivery of chlorthiazide using bioadhesive polymer. J Pharm Sci 74: 406-410.
Lu E, Jiang Z, Jiang X and Zhang Q. (2002). Preparation of controlled release coated tablets of naproxen sodium. Zhongguo Yaoxue Zazhi 37: 841-844.
Maggi L, Bruni R and Conte U. (2000). Highly swellable, multilayer tablets to prolong the residence time of the delivery device in the stomach. J Control Release 64: 269-270.
Mako to Ishida, Abe K, Hashezime M and Kawamura M. (2008). A novel approach to sustained pseudoephedrine release: Differentially coated Mini-tablets in HPMC capsules. Int J Pharm 359: 46-52.
Marcos BP, Ford JL, Armstrong DJ, Elliott PN, Rostron C and Hogan JE. (1996). Influence of pH on the release of propranolol hydrochloride from matrices containing hydroxypropyl-methylcellulose K4M and Carbopol 974. J Pharm Sci 85: 330-334.
Masri S, Moor E, Kirmayer D, Kluev E, Carni G and Navon N. (2010). Zaleplon gastroretentive drug delivery system, WO/2010/064139.
Masri S, Moor E, Kirmayer D, Kluev E, Carni G and Navon N. (2012). Zaleplon gastroretentive drug delivery system. US 20120021051.
Matharu RS and Sanghavi NM. (1992). Novel drug delivery system for captopril. Drug Dev Ind Pharm 18: 1567-1574.
Matsumara M, Nakagami H, Yamao T, Takayama K and Nagai T. (1994). Computer optimization for the formulation of controlled release theophylline tablet made of micronized low substituted hydroxypropylcellulose and methylcellulose. Chem Pharm Bull 42: 1902-1908.
Menon A, Ritschel W. A and Saka A. (1993). Development and evaluation of monolithic floating dosage form for furosemide. J Pharm Sci 83: 239-245.
Menon A, Ritschel WA and Sakr A. (1994). Development and evaluation of a monolithic floating dosage form for furosemide. J Pharm Sci 83: 239-245.
Mesiha MS and Rivera D. (1994). Factorial design of phenylpropano-lamine prolonged release tablet formulations using fluid bed dryer granulator. Drug Dev Ind Pharm 20: 31-48.
Meyer JHD, Fink A and Amodon G. (1985). Effect of size and density on canine gastric emptying of nondigestible solids. Gastroenterol 89: 805-811.
Michaels AS. (1975). Drug delivery device with self-activated mechanism for retaining device in selected area. US3786813.
Minarro M, Garcia-Montoya E, Sune-Negre JM and Tico JR. (2001). Study of formulation parameters by factorial design in metoprolol tartrate matrix systems. Drug Dev Ind Pharm 27: 965-973.
Mitra SB. (1984). Sustained-release oral medicinal delivery devices. US, 4451260.
Miyazaki S, Nakayama A, Oda M, Takada M and Attwood D. (1994). Chitosan and sodium alginate based bioadhesive tablets for intraoral drug delivery. Biol Pharm Bull 17: 745-747.
Moes AJ. (2012). Gastroretentive dosage forms. Crit Rev Ther Drug Carrier Syst 1993 10: 143-195.
Mohd Abdul Hadi, Rao NGR and Firangi S. Mini - Tablets Technology: An Overview. Am. J PharmTech Res 2(2): 128-150.
Mojaverian P, Fergusan RK, Vlasses PH, Rocu ML, Oren A, Fix JA, Caldwell LJ and Gardner C. (1988). Effect of gender, posture and age on gastric residence time of an indigestible solid: Pharmaceutical considerations. Pharm Res 5: 639-644.
Morimoto K, Morisaka K and Kamada A. (1985). Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel. J Pharm Pharmacol 37: 134-136.
Morishita M and Takayama K. (2001). Application of pH-responsive polymers to oral dosage forms for insulin. Nippon Rinsho 59: 2255-2260.
Muller RH and Jacobs C. (2002). Buparvaquone mucoadhesive nanosuspension: Preparation, optimisation and long-term stability. Int J Pharm 237: 151-161.
Murata Y, Kafuji K and Kawashima S (2003). Preparation of floating alginate gel beads for drug delivery to the gastric mucosa. J Biomater Sci Polym Ed. 14: 581-588.
Muthusamy K, Govindarazan G and Ravi TK. (2005). Preparation and evaluation of lansoprazole floating micropellets, Ind J Pharm Sci 67: 75-79.
Nakamichi K, Yasuura H, FuKui H, Oka M and Izumi S. (2001). Evaluation of a floating dosage form of nicardipine hydrochloride and hydroxypropylmethylcellulose acetate succinate prepared using a twin-screw extruder. Int J Pharm 218: 103-112.
Nakamura F, Ohta R, Machida Y and Nagai T. (1996). In vitro and in vivo nasal mucoadhesion of some water-soluble polymers. Int J Pharm 134: 173-181.
Narendra C, Srinath MS and Babu G. (2006). Optimization of bilayer floating tablet containing metoprolol tartrate as a model drug for gastric retention. AAPS Pharm Sci Tech 7: E34.
Navon N, Moor E, Kirmayer D, Kluev E and Carni G. (2014). Carbidopa/Levodopa gastroretentive drug delivery, US 8771730.
Navon N, Shvetz J, Moor E, Kirmayer D, Kluev E and Carni G. (2010). Baclofen gastroretentive drug delivery system. WO/2010/ 064100.
Navon N, Shvetz J, Moor E, Kirmayer D, Kluev E, Masri S, Carni G and Weiss Z. (2011). Baclofen and r-baclofen gastroretentive drug delivery systems, US20110091542.
Nur AO and Zhang JS. (2000). Recent progress in sustained/ controlled oral delivery of captopril: An overview. Int J Pharm 194: 139-146.
Ortigosa C, Guady D, Jacob M and Puech A. (1991). The role of Gelucire in the availability of theophylline in semisolid matrix capsules. Pharm Acta Helv 66: 311-315.
Oth M, Franz M, Timmermans J and Moes A. (1992). The bilayer floating capsule: A stomach-directed drug delivery system for misoprostol. Pharm Res 9: 208-302.collins
Ozdemer N, Ordu S and Ozkan Y. (2000). Studies of floating dosage forms of furosemide: In vitro and in vitro evaluations of bilayer tablet formulations. Drug Dev Ind Pharm 26: 857-866.
Palin KJW, DR, Wilson CG, Davis SS and Philips AJ. (1982). Determination of gastric emptying profiles in the rat : Influence of oil structure and volume. Int J Pharm 12: 315-323.
Panagopoulous A and Georgarakis M. (1990). Effect of compression and diluent on drug release from mastrix matrix tablets. A statistical analysis. Drug Dev Ind Pharm 16: 637-649.
Parikh RH, Parikh JR, Dubey RR, Soni HN and Kapadia KN. (2003). Poly(d,l-lactide-co-glycolide) microspheres containing 5-fluorouracil: Optimization of process parameters. AAPS Pharm Sci Tech 4: 103-110.
Park H, Kelly P and Robinson JR. (1985). Bioadhesive polymers as platforms for oral controlled drug delivery. Part 2. Synthesis and evaluation of some swelling, water insoluble bioadhesive polymers. J Pharm Sci 74: 399-405.
Park K and Robinson R. (1984). Bioadhesive polymers as platforms for oral controlled drug delivery: Method to study bioadhesion. Int J Pharm 19: 107-127.
Parojcic J, Ðuric Z, Jovanovic M and Ibric S. (2004). An investigation into the factors influencing drug release from hydrophilic matrix tablets based on novel carbomer polymers. Drug Deliv. 11: 59-65.
Patel JK, Patel RP, Amin AF and Patel MM. (2005). Formulation and Evaluation of Mucoadhesive Glipizide Microspheres AAPS PharmSciTech 06: E49-E55.
Patel VF and Patel NM. (2006). Intragastric floating drug delivery system of cefuroxime axetil: in vitro evaluation. AAPS Pharm SciTech 7: E17.
Pena-Romero A, Poncet M, Jinot J and Chulia D. (1988b). Statistical optimization of a sustained release form of sodium diclofenac on inert matrices. Part 2. Statistical optimization. Pharm Acta Helv 63: 333-342.
Pena-Romero A., Poncet M, Jinot J and Chulia D. (1988a). Statistical optimization of a controlled release formulation of diclofenac sodium from inert matrices. Part 1. Aptitude for compression and preliminary discussion. Pharm Acta Helv 63: 309-314.
Perez-Marcos B, Iglesias R, Gomez-Amoza JL, Martinez-Pacheo R, Souto C and Conchiero R. (1991). Mechanical and drug release properties of atenolol-carbomer hydrophilic matrix tablets. J Control Release 17: 267-276.
Pillay V, Choonara Y, Murphy C and Moonisami S. (2011). Gastroretentive pharmaceutical dosage form, US 20110182988
Pillay V and Fassihi R. (1998). Evaluation and comparison of dissolution data derived from different modified release dosage forms: An alternative method. J Control Release 55: 45-55.
Plaizier-Vercammen J, Dauwe D and Brioen P. (1997). Possibility of the use of Eudragit RS as a sustained-release matrix agent for the incorporation of water-soluble active compounds at high percentages. STP Pharm Sci 7: 491-497.
Ratsimbazafy V and Brossard C. (1992). Optimization of the release of theophylline derivatives from Gelucire matrices. Pharm Acta Helv 67: 166-171.
Rekhi GS, Nellore RV, Hussain AS, Tillman LG, Malinsowski HJ and Augsburger LL. (1999). Identification of critical formulation and processing variables for metoprolol tartarate extended release (ER) matrix tablets. J Control Release 59: 327-342.
Riley RG, Green KL, Smart JD, Tsibowklis J, Davis JA, Hampson F, Dettmar PW and Wilber WR. (2001a). The gastrointestinal transit profile of C-14-labelled poly(acrylic acids): an in vivo study. Biomaterials. 22: 1861-1867.
Riley RG, Smart JD, Tsibouklis J, Dettmar PW, Hampson F, Davis JA, Kelly G and Wilber WR. (2001b). An investigation of mucus/polymer rheological synergism using synthesized and characterized poly(acrylic acid). Int J Pharm 217: 87-100.
Ritchel WA, Menon A and Sakr A. (1991). Biopharmaceutic evaluation of furosemide as a potential candidate for a modified release peroral dosage form. Clin Pharmacol 13: 629-636.
Robinson JR. (1988). Bioadhesion in drug delivery. Ind J Pharm Sci 50: 145-152.
Rocca JG, Omidian H and Shah K. (2003). Progresses in Gastroretentive Drug Delivery Systems. Business Briefing Pharm Tech pp. 152-156.
Roldo M, Hornof M, Caliceti P and Bernkop-Schnurch A. (2004). Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: Synthesis and in vitro evaluation. Eur J Pharm BioPharm 57: 115-121.
Rouge N, Buri P, Doelker E, Cole ET and Doelkar E. (1998). Buoyancy and drug release patterns of floating minitablets containing piretanide and atenolol as model drugs. Pharm Dev Techn 3: 73-84.
Rouge N, Buri P and Doelker E. (1996). Drug absorption site in the gastrointestinal tract and dosage forms for site-specific delivery. Int J Pharm 136: 117-139.
Russel J and Bass P. (1985). Canine gastric emptying of polycarbophil: An indigestible particulate substance. Gastroenterol. 89: 307-312.
Saettone MFM, D., Torracca MT and Chetoni P. (1994). Mucoadhesive ophthalmic vehicles: Evaluation of polymeric low-viscosity formulations. J Ocul Pharmacol 10: 83-92.
Sakagami M, Kinoshita W, Sakon K, Sato J and Makino Y. (2002). Mucoadhesive beclomethasone microspheres for powder inhalation: Their pharmacokinetics and pharmacodynamics evaluation. J Control Rel. 80: 207-218.
Sakagami M, Sakon K, Kinoshita W and Makino, Y. (2001). Enhanced pulmonary absorption following aerosol administration of mucoadhesive powder microspheres. J Control Rel 77: 117-129.
Sakr A and Tillotson J (2004). Effect of extended-release polymer concentration and pH and solubility modifiers on the release of a weakly acid drug from an extended-release, matrix tablet. In: Proceedings of Annual Meeting of American Association of AAPS Maryland, USA. Abstract 000526.
Sakuma S, Sudo R, Suzuki N, Kikuchi H, Akashi M, Ishida Y and Hayashi M. (2002). Behavior of mucoadhesive nanoparticles having hydrophilic polymeric chains in the intestine. J Control Release 81: 281-290.
Sanchez-Lafuente C, Furlanetto S, Fernandez-Arevalo M, Alvarez-Fuentes J, Rabasco AM, Faucci MT, Pinzauti S and Mura P. (2002). Didanosine extended-release matrix tablets: Optimization of formulation variables using statistical experimental design. Int J Pharm 237: 107-118.
Sangekar S, Vadino WA, Chaudry I, Parr A, Behin R and Digenis G. (1987). Evaluation of effect of food and specific gravity on tablets on gastric retention time. Int J Pharm 35: 187-191.
Sanjay Dey, Sankha C and Bhaskar M. (2014). Formulation and Evaluation of Fixed-Dose Combination of Bilayer Gastro-retentive Matrix Tablet Containing Atorvastatin as Fast-Release and Atenolol as Sustained-Release. BioMed Res Int doi: 10.1155/2014/396106.
Sato Y, Kawashima Y, Takeuchi H and Yamamoto H. (2003a). Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur. J Pharm Bio Pharm 55: 297-304.
Sato Y, Kawashima Y, Takeuchi H and Yamamoto H. (2003b). In vivo evaluation of riboflavin-containing microballoons for floating controlled drug delivery system in healthy human volunteers. J Control Release 93: 39-47.
Sato Y, Kawashima Y, Takeuchi H and Yamamoto H. (2004). In vitro evaluation of floating and drug releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm BioPharm 57: 235-243.
Sawicki W and Glod J. (2004). Preparation of floating pellets with verapamil hydrochloride. Acta Pol. Pharm 61: 185-190.
Schmitz T, Leitner VM and Bernkop-Schnurch A. (2005). Oral heparin delivery: design and in vivo evaluation of a stomach-targeted mucoadhesive delivery system. J Pharm Sci 94: 966-973.
Seta YHF, Kawaraha Y, Nishimura K and Okada R. (1988). Design and preparation of captopril sustained-release dosage forms and their biopharmaceutical properties. Int J Pharm 41: 245-254.
Shah N, Zhang G, Apelian V, Zeng F, Infeld MH and Malick AW. (1993). Prediction of drug release from hydroxypropyl methylcellulose (HPMC) matrices: Effect of polymer concentration. Pharm Res 10: 1693-1695.
Shah S, Morris J, Sulaiman A, Farhadieh B and Truelove J. (1992). Development of misoprostol 3 hour controlled release formulations using response surface methodology. Drug Dev Ind Pharm 18: 1079-1098.
Sheng HL, Wang P, Tu JS, Yuan L and Pin QN. (1998). Application of artificial neural networks for formulation designing of matrix tablets. Zhongguo Yiyao Gongye Zazhii. 29: 352-354.
Sheth PR and Tossounian JL. (1984). The hydrodynamically balanced system (HBSTM): A novel drug delivery system for oral use. Drug Dev Ind Pharm 10: 313-339.
Shimpi S, Chauhan B, Mahadik KR and Paradkar A. (2004). Preparation and evaluation of diltiazem hydrochloride-Gelucire 43/01 floating granules prepared by melt granulation. AAPS Pharm Sci Tech 5: Article 43.
Shivkumar HN, Sarosija S and Desai BG. (2007). Design and evaluation of pH sensitive mini-tablets for Chronotherapeutics delivery of theophylline. Ind J Pharm Sci 69: 73-79.
Singh B and Agarwal R. (2002). Design, development and optimization of controlled release microcapsules of diltiazem hydrochloride. Ind J Pharm Sci 64: 378-385.
Singh B and Ahuja N. (2002). Development of controlled release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: Optimization of bioadhession, dissolution and diffusion parameters. Drug Dev Ind Pharm 28: 433-444.
Singh B, Bakshi M, Agrawal R and Babu MR. (1998). Optimization of lipid matrix formulations of captopril through response surface methodology. 50th Indian Phamaceutical Congress, Mumbai, Abstract IAP 37.
Singh B, Buhary MS, Ahuja N and Chaturvedi SC. (2002). Formulation optimization and characterization of hydrophilic matrices of verapamil hydrochloride using central composite design (CCD). Proc. 54th Indian Pharmaceutical Congress. Pune.
Singh B, Chakkal SK and Ahuja N. (2006a). Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS Pharm Sci Tech pp. E1- E10.
Singh B, Chakkal SK and Dhiman A. (2003a). Osmotically-driven oral drug delivery system: Need of the hour -II: Express Pharma Pulse 9: 25-26.
Singh B, Dahiya M, Saharan V and Ahuja N. (2005b). Optimizing drug delivery systems using “Design of Experiments” Part II: Retrospect and Prospects. Crit Rev Ther Drug Carrier Syst. 22: 215-292.
Singh B, Gupta RK and Ahuja N (2005d). Computer-assisted optimization of pharmaceutical formulations and processes. 10th chapter, in Pharmaceutical Product Development, Jain, N. K. (ed.) CBS Publishers, New Delhi, pp. 273-381.
Singh B and Gupta RK (1997). Formulation and optimization of controlled release tablet dosage forms. M. Pharm Thesis. Panjab University, Chandigarh, December.
Singh B, Kumar R and Ahuja N. (2005e). Optimizing drug delivery systems using “Design of Experiments” Part I: Fundamental Aspects. Crit Rev Ther Drug Carrier Syst 22: 27-106.
Singh B and Mattu V (2006b). Formulation and optimization of controlled release transdermal gel of tenoxicam, M. Pharm Thesis. Panjab University, Chandigarh, December.
Singh B and Singh S. (1998). A comprehensive computer program for study of drug release kinetics from compressed matrices. Ind J Pharm Sci 60: 313-316
Singh BN and Kim KH. (2000). Floating drug delivery systems: An approach to oral controlled drug delivery via gastric retention. J Control Release 63: 235-259.
Singh (2006d). Fomulation and optimization of floating-bioadhesive drug delivery system of verapamil hydrochloride. 25th IPC Conference, Mumbai.
Singh (2006c). Formulation and optimization of self nano emulsifying drug delivery system of Carvedilol. 25th IPC Conference, Mumbai.
Smart JD, Kellaway IW and Worthington HEC. (1984). An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J Pharm Pharmacol 36: 295-299.
Smart JD. (2004). Recent developments in the use of bioadhesive systems for delivery of drugs to the oral cavity. Crit Rev Ther Drug Carrier Syst 21: 319-344.
Smart JD. (1992). Some formulation factors influencing the rate of drug release from bioadhesive matrices. Drug Dev Ind Pharm 18: 223-232.
Soane RJ, Frier M, Perkins AC, Jones NS, Davis SS and Illum L. (1999). Evaluation of the clearance characterstics of bioadhesive systems in humans. Int J Pharm 178: 55-65.
Soppimath KS, Kulkarni AR and Aminabhavi JM. (2001a). Development of hollow microspheres as floating controlled release systems for cardiovascular drugs: Prepration and release characteristics. Drug Dev Ind Pharm 27: 507-51.
Soppimath KS, Kulkarni AR and Rudzinski WE. (2001b). Microspheres as floating drug delivery systems to increase gastric retention of drugs. Drug Met Rev 33: 149-160.
Squier CA and Wertz P (1992). Structure and function of oral mucosa and implication for drug delivery, Marcel Dekker, New York. 74: 1-27.
Sriamornsak P, Thirawong N and Puttipipatkharhom S. (2005). Emulsion gel beads of calcium pectinate capable of floating on the gastric fluid: effect of some additives, hardening agent or coating on release behavior of metronidazole. Eur J Pharm Sci 24: 363-373.
Srivastava AK, Ridhurkar DN and Wadhwa S. (2005a). Floating microspheres of cimetidine: Formulation, characterization and in vitro evaluation. Acta Pharm 55: 277-285.
Srivastava AK, Wadhwa S, Ridhurkar D and Mishra B. (2005b). Oral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluation. Drug Dev Ind Pharm 31: 367-374.
Stepensky D, Friedman M, Srour W, Raz I and Hoffman A. (2001). Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metformin formulation. J Control Release 71: 107-115.
Stithit S, Chen W and Price JC. (1998). Development and characterisation of buoyant theophylline microspheres with near zero-order release kinetics. J Microencapsul 15: 725-737.
Streubel A, Siepmann J and Bodmeier R. (2002). Floating microparticles based on low density foam powder. Int J Pharm 241: 279-292.
Streubel A, Siepmann J and Bodmeier R. (2003). Floating matrix tablets based on low density foam powder: Effects of formulation and processing parameters on drug Release. Eur J Pharm Sci 18: 37-45.
Sung CK, Nixon PR, Skoug JW, Ju TR, Gao P, Topp EM and Patel M. (1996). Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets. Int J Pharm 142: 53-60.
Takahara J, Takayama K and Nagai T. (1997). Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations. J Control Release 49: 11-20.
Takishima J, Onishi H and Machida Y. (2002). Prolonged intestinal absorption of cephradine with chitosan-coated ethylcellulose microparticles in rats. Biol Pharm Bull 25: 1498-1502.
Takka S, Ocak OH and Acarturk F. (1998). Formulation and investigation of nicardipine HCl-alginate gel beads with factorial design-based studies. Eur J Pharm Sci 6: 241-246.
Talukder R and Fassihi R. (2004). Gastroretentive Delivery Systems: A Mini Review. Drug Dev Ind Pharm 30: 1019-1028.
Thanoo BC, Sunny MC and Jayakrishnan A. (1993). Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on the gastric fluid. J Pharm Pharmacol 45: 21-24.
Tillotson J and Sakr A. (2004). Application of multiple-response optimization to fluoride release from an extended-release matrix tablet. Pharm Ind 66: 601-606.
Timmermans J and Moes AJ. (1990). How well do floating dosage forms float? Int J Pharm 62: 207-216.
Timmermans J and Moes AJ. (1994). Factors controlling the buoyancy and gastric retention capabilities of floating matrix capsules: New data for reconsidering the controversy. J Pharm Sci 83: 18-24.
Timmins P., Delargy AM and Howard JR. (1997). Optimization and characterization of a pH-independent extended-release hydrophilic matrix tablet. Pharm Dev Technol. 2: 25-31.
Tucker IG, Szylkarski HA and Romaniuk K. (1989). The behaviour of bioadhesive betamethasone tablets in the mouth. J Clin. Pharm Ther 14: 153-158.
Uko Nne SD, Mendas RW and Jambhekar SS. (1989). Dried molasses as a direct compression matrix for oral controlled release drug delivery II: Release mechanism and characteristics of theophylline from a molasses-HPMC matrix. Drug Dev Ind Pharm 15: 719-741.
Umamaheshwari RB, Jain S, Bhadra D and Jain NK. (2003). Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori. J Pharm Pharmacol 55: 1607-1613.
Umamaheshwari RB, Jain S, Tripathi PK, Agarwal GP and Jain NK. (2002). Floating-bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori. Drug Deliv 9: 223-231.
Umezawa H. (1998). Pepstatin floating minicapsules. US 4, 101, 650.
Uraizee SA, McPhillips AM, Ritschel WA and Sakr A. (1999). Development of a targeted mucoadhesive drug delivery system for the peroral administration of insulin. Pharm Ind 61: 569-573.
Uraizee SA, McPhillips AM, Ritschel WA and Sakr A. (2000). Development of a targeted mucoadhesive drug delivery system for the peroral administration of insulin. Drugs Made in Germany. 43: 41-44.
Varshosaz J, Tavakoli N and Roozbahani F. (2006). Formulation and in vitro characterization of ciprofloxacin floating and bioadhesive extended-release tablets. Drug Deliv 13: 277-85
Vatsaraj N, Zia H and Needham T. (2002). Formulation and optimization of a sustained-release tablet of ketorolac tromethamine. Drug Deliv 9: 153-159.
Vazquaz MJ, Perez-Marcos B, Gomez-Amoza JL and Peppas NA. (1992). Influence of technological variables on release of drugs from hydrophilic matrices. Drug Dev Ind Pharm 18: 1355-1375.
Vyas SP and Jain CP. (1992). Bioadhesive polymer-grafted starch microspheres bearing isosorbide dinitrate for buccal administration. J Microencapsul 9: 457-464.
Waaler P, Graffner C and Muller BW. (1992a). Optimization of a matrix tablet formulation using a mixture design. Acta Pharm Nord 4: 9-16.
Waaler PJ, Arnesen K, Graffner C and Muller BW. (1992b). Optimization of the amount of xanthan gum and guar gum in a matrix tablet formulation using a central composite design. Acta Pharm Nord. 4: 291-296.
Wake WC. (1978). Theories of adhesion and uses of adhesives: A review. Polymer. 19: 291-308.
Watanabe S, Kayano M, Ishino Y and Miyao K. (1976). Solid therapeutic prepration remaining in stomach. US 3976764.
Wehrlé P and Stamm A. (1994). Statistical tools for process control and quality improvement in the pharmaceutical industry. Drug Dev Ind Pharm 20: 141-164.
Wei Z, Yu Z and Bi D. (2001). Design and evaluation of a two-layer floating tablet for gastric retention using cisapride as a model drug. Drug Dev Ind Pharm 27: 469-474.
Weitschies W, Kotitz R, Cordini D, Trahms l and Semmler W. (1999). Magnetic marker monitoring of esophageal, gastric and duodenal transit of nondisintegrating capsules. Pharmazie 54: 426-430.
Weitschies W, Kotitz R, Cordini D and Trahms. (1997). High resolution monitoring of the gastrointestinal transit of a magnetically marked capsule. J Pharm Sci 86: 1218-1222.
Westerhuis JA, Coenegracht PMJ and Lerk CF. (1997). Multivariate modelling of the tablet manufacturing process with wet granulation for tablet optimization and in process Control. Int J Pharm 156: 109-117.
Whitehead L, Collett JH and Fell JT. (2000). Amoxycillin release from a floating dosage form based on alginates. Int J Pharm 210: 45-49.
Wilding IR, Coupe AJ and Davis SS. (2001). The role of [gamma]-scintigraphy in oral drug delivery. Adv. Drug Del. Rev 46: 103-124.
Wilding IR, Davis SS, Melia CD, Hardy JG, Evans DF, Short AH and Sparrow RA. (1989). Gastrointestinal transit of Sinemet CR in healthy volunteers. Neurolog 39: 53-58 (Suppl. 2).
Wilson CG and Washington N (2000). Handbook of pharmaceutical controlled release technology. In: Wise, D. L. (ed.). Marcel Dekker, New York, pp. 551-565.
Wilson CG and Washington N (1989). The stomach: Its role in oral drug delivery. In: Rubinstein, M.H. (ed.) Physiological Pharmaceutics: Biological Barriers to Drug Absorption. Ellis Harwood, Chechester, pp. 47-70.
Woodley J. (2001). Bioadhesion: New possibilities for drug administration? Clin. Pharmacokinet 40: 77-84.
Wu T, Pan W, Chen J and Zhang R. (2000). Formulation optimization technique based on artificial neural network in salbutamol sulfate osmotic pump tablets. Drug Dev Ind Pharm 26: 211-215.
Wu W, Zhou Q, Zhang HB, Ma GD and Fu CD. (1997). Studies on nimodipine sustained release capsule capable of floating on gastric fluid with prolonged gastric resident time. Yao Xue Xue Bao 32: 786-790.
Yang L and Fassihi R. (1996). Zero order release kinetics from a self correcting floatable asymmetric configuration drug delivery system. J Pharm Sci 85: 170-173.
